Opciones terapéuticas actuales en la enfermedad de graves basedow

Abstract

Introduction: Graves-Basedow disease is an autoimmune disease that affects the thyroid gland in the first instance, even affecting many other organs, including the eyes and skin. It is considered the most common cause of hyperthyroidism with a higher incidence in women than in men. The hyperthyroidism clinic is evaluated through complementary tests, trying to know how the pituitary-thyroid axis is, for which laboratory tests are indicated that allow knowing the status of the thyroid hormones. The treatment of this pathology is based on the control of symptoms and the decrease in thyroid hormone secretion. Objective: To identify the main aspects related to the updated management of Graves-Basedow disease. Materials and Method: A bibliographic review of updated scientific articles published in the Pubmed and Scielo databases in the last 5 years was carried out, which were mainly selected from the quartiles belonging to Scimago Journal Rank. Conclusions: Graves-Basedow disease is an autoimmune entity that affects various organs; its presentations are diverse and, therefore, the disorder is best managed by a multiprofessional team. Although antithyroid medications control symptoms, they do not cure the disease and, therefore, relapses are common, so the treatment for this pathology is clinical and surgical, such as the use of beta-blockers, antithyroid drugs, radioactive iodine and thyroidectomy.